138 related articles for article (PubMed ID: 8157278)
1. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
Schlesinger BC; Cheng L
Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
[TBL] [Abstract][Full Text] [Related]
2. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
Montel AH; Bochan MR; Goebel WS; Brahmi Z
Cell Immunol; 1995 Oct; 165(2):312-7. PubMed ID: 7553897
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
5. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
Hommel-Berrey G; Bochan M; Brahmi Z
Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
7. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
Bochan MR; Goebel WS; Brahmi Z
Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
[TBL] [Abstract][Full Text] [Related]
8. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
Kägi D; Ledermann B; Bürki K; Seiler P; Odermatt B; Olsen KJ; Podack ER; Zinkernagel RM; Hengartner H
Nature; 1994 May; 369(6475):31-7. PubMed ID: 8164737
[TBL] [Abstract][Full Text] [Related]
10. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis.
Shinkai Y; Ishikawa H; Hattori M; Okumura K
Eur J Immunol; 1988 Jan; 18(1):29-33. PubMed ID: 3345794
[TBL] [Abstract][Full Text] [Related]
11. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
13. Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
Allbritton NL; Nagler-Anderson C; Elliott TJ; Verret CR; Eisen HN
J Immunol; 1988 Nov; 141(10):3243-8. PubMed ID: 3263417
[TBL] [Abstract][Full Text] [Related]
14. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
15. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
16. Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis.
De Leon M; Jackson KM; Cavanaugh JR; Mbangkollo D; Verret CR
J Cell Biochem; 1998 Jun; 69(4):425-35. PubMed ID: 9620169
[TBL] [Abstract][Full Text] [Related]
17. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
[TBL] [Abstract][Full Text] [Related]
18. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
19. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells.
Zuber B; Levitsky V; Jönsson G; Paulie S; Samarina A; Grundström S; Metkar S; Norell H; Callender GG; Froelich C; Ahlborg N
J Immunol Methods; 2005 Jul; 302(1-2):13-25. PubMed ID: 16005014
[TBL] [Abstract][Full Text] [Related]
20. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS
Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
